Clinical Trial

Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study will primarily identify longitudinal associations between cardiorespiratory fitness (CRF) and cognitive function pre- (baseline) to post-chemotherapy (\~3 months). This will be a prospective study of 50 BCS. We hypothesize that breast cancer patients undergoing chemotherapy who have higher levels of CRF at baseline will have significantly improved measures of attention, executive function, and memory post-chemotherapy. In addition, the exploratory aims will examine the longitudinal associations between physical activity (PA) and cognitive function from pre- to post-chemotherapy and explore the associations between inflammatory and non-inflammatory biomarkers and CRF with cognitive function.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-11-02; most recent amendment 2024-12-03.
Trial Details
NCT Number NCT04616300
Lead Sponsor University of Toronto
Conditions Breast Cancer
Enrollment 50 participants
Start Date 2019-12-12
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-06